AzTrials
AzTrials

Vaccination PromotionNCT05093452

MOTIVAC-MATER-Confiance

A study testing Motivational Interviewing and Information flyer in people with Vaccination Promotion, run by Observatoire Regional de la Sante Provence-Alpes-Côte d'Azur at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

CONTEXT Vaccination has reduced mortality and morbidity by controlling many vaccine-preventable diseases. To prevent recurrence of these diseases, high vaccine coverages (VCs) (≥ 95%) are needed. But VCs for infants remain suboptimal, and four out of 10 parents doubt the safety and efficacy of vaccines in France. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Vaccination Promotion
What is being tested?
Motivational Interviewing and Information flyer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
736 participants
Where
2 sitesFrance
Study dates
8 Nov 2021to 9 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Mothers aged 18 years or more
  • Mothers residing in the PACA region (Provence-Alpes-Côtes-d'Azur) at the time of the delivery
  • Mothers who can read and speak French
  • Mothers able to give a free and informed consent
  • Mothers who provide written consent

Who cannot join

  • Mothers of new-born needing to be transferred in a 3rd level maternity ward (because of severe condition)
  • Mothers who will leave early maternity ward (<24h)

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Hôpital Saint-Joseph

    Marseille, 13008

  • Hôpital Sainte-Musse

    Toulon, 83100

Other trials in France

About this study

Official title: Motivational Interviewing of Parents in Maternity Wards About Vaccination (Entretien Motivationnel Sur la Vaccination auprès Des Parents Dans Les maternités)

CONTEXT Vaccination has reduced mortality and morbidity by controlling many vaccine-preventable diseases. To prevent recurrence of these diseases, high vaccine coverages (VCs) (≥ 95%) are needed. But VCs for infants remain suboptimal, and four out of 10 parents doubt the safety and efficacy of vaccines in France. The Ministry of Health therefore decided in July 2017 to expand vaccination requirements to 11 valences now required to enter in young children collective structures. This measure, which went into effect in January 2018, has produced significant effects on VCs, but despite this, vaccine hesitancy (VH) persists in the general population at a prevalence level that fluctuates around 20% to 25%.

Motivational interviewing is a collaborative conversational style that reinforces a person's own motivation and commitment to behavior change. It has been successfully tested in multiple domains related to health behavior change. It has also been adapted in Quebec in the area of vaccination and tested in maternity wards with postpartum mothers (Promovac study). Having led to an increase in the VCs of infants by an average of 7 percentage points and a 40% decrease in vaccine hesitancy, this approach has been in the process of being generalized to all maternity units in Quebec since 2017 (EMMIE program). It is indeed proving to be one of the most effective at present in improving confidence in early childhood vaccines.

Read more

OBJECTIVES The main objective of this research is to provide proof of concept that, in the French context of mandatory vaccination for infants but also of high rates of VH, an educational strategy based on the principles and techniques of motivational interviewing and carried out with parents in the maternity ward in the days following delivery can reduce vaccine hesitancy (VH).

The secondary objectives are as follows:

  • to verify that this reduction in VH is associated with a change in knowledge, attitudes, and beliefs regarding vaccines;
  • to verify that this reduction is sustainable (at 12 months);
  • to evaluate the acceptability and satisfaction of the interview for the parents

METHODS This is a pragmatic randomized controlled multicenter study with individual randomization unit comparing the impact of motivational interviewing to a standard care with a leaflet on vaccination.

Motivational interviewing will be carried out by trained midwives from the two participating maternity units (one in Marseille (Bouches-du-Rhône) and the other in Toulon (Var)), as part of the routine care provided to parturients. The midwives will be trained by the founding specialist of motivational interviewing in Quebec, during a two and a half day training course. This training will include a presentation of the theoretical foundations of this approach, its adaptation to the field of vaccination, and interactive games to put it into practice. The trained midwives will then be able to put this approach into practice during a one-month pilot period with parturients, during which they will be able to benefit from support in the form of a debriefing. The actual survey will only start at the end of this pilot phase.

In each group, a questionnaire will be offered to the women (couples) who have agreed to participate, both before the motivational interview (or delivery of the leaflet) and after the interview (or delivery of the leaflet). The second questionnaire will be completed before discharge from the maternity hospital. A third evaluation time is planned at 12 months in both groups: it will be carried out by internet or telephone.

The primary endpoint will be the change in the vaccine hesitancy score, measured by an international scale validated in French (Opel scale).

Secondary endpoints will be changes in knowledge, attitudes and beliefs about vaccination between the two groups as well as satisfaction with the ME and the brochure.

Randomization will be performed in blocks of 8, prior to acceptance for participation in this research.

EXPECTED BENEFITS If the results of this research provide proof of concept that the educational strategy based on motivational interviewing adapted to the vaccination of infants after delivery, in maternity wards, makes it possible, in the French context, to reduce VH, this will be a major advance in public health in France. Indeed, even if the vaccination obligations introduced in January 2018 have had a positive impact on infant vaccination coverage, VH remains present in parents in a proportion that remains worrying (20 to 25% according to surveys). The results of this research will then allow us to study the conditions for generalizing motivational interviewing in order to reinforce confidence in vaccination, which is lacking in a significant part of the French population.

Being tested
Motivational Interviewing, Information flyer
Keywords
Vaccine hesitancy, Motivational interviewing, Childhood vaccination
Medical subject headings
Vaccination Hesitancy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational InterviewingBehavioural

    Mothers randomized in the intervention group will receive an educational session based on the motivational interviewing (MI) approach with a midwife. The midwife will have first received a standardized 3 days training session on the content and techniques of MI. The MI intervention will be carried out in simple and understandable language in order to allow discussion and questions from parents rather than provide prescriptive and direct information. The intervention will last approximatively 15 to 20 minutes.

  • Information flyerOther

    Mothers randomized in the control group will receive a locally information flyer on childhood vaccines without any oral explanation by the midwife.

Study groups in NCT05093452
Study groupRoleWhat they receive
Motivational interviewingExperimentalEducational session based on the motivational interviewing
Receives: Behavioral: Motivational Interviewing
Information flyerOtherInformation flyer on childhood vaccines
Receives: Other: Information flyer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vaccine hesitancy score (Opel score)

    Parents' vaccine hesitancy score, regarding vaccination of their child, assessed by a questionnaire before and after the intervention at the maternity ward. Using the Opel score (Opel. Validity and reliability of a survey to identify vaccine-hesitant parents. Vaccine. 2011)

    Measured: During the 72-hour postpartum stay at the maternity ward

  2. Knowledge, attitudes, and beliefs regarding vaccines

    Parents' knowledge, attitudes, and beliefs regarding vaccines, assessed by a questionnaire before and after the intervention at the maternity ward. Using the PromovaQ questionnaire, which was constructed and developed using a composite model inspired by the Health Belief Model and the Theory of Planned Behavior.

    • Dubé. Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada. Human Vaccines \& Immunotherapeutics. 2018.
    • Gagneur. Promoting vaccination in maternity wards - motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015. Euro Surveillance. 2019.
    • Gagneur. Promoting vaccination in the province of Québec, the PromoVaQ randomized controlled trial protocol. BMC Public Health. 2019.)

    Measured: During the 72-hour postpartum stay at the maternity ward

  3. Vaccine hesitancy score (Opel score) (sustainability)

    Parents' vaccine hesitancy score, regarding vaccination of their child, assessed at 12 months by an online or by-phone questionnaire.

    Measured: 12 months after the intervention at the maternity ward

  4. Acceptability and satisfaction of the interview for the parents

    Parents' acceptability and satisfaction of the interview assessed by a questionnaire after the intervention (MI or leaflet) at the maternity ward.

    Measured: During the 72-hour postpartum stay at the maternity ward

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2021
  2. Study start8 Nov 2021
  3. Primary completion26 Apr 2022
  4. Study completion9 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
736 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05093452
Sponsor's protocol ID
2021-01-07-04
Status last verified
Nov 2023
First submitted
24 Sep 2021
Last updated
3 Nov 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ramalli L, Cogordan C, Fressard L, Donato X, Biferi M, Verlomme V, Sonnier P, Meur H, Maradan G, Berenger C, Berthiaume P, Gagneur A, Verger P. Sustained impact of motivational interviewing on reducing vaccine hesitancy among postpartum mothers: A randomized control trial, Southeastern France, 2021 to 2022. Hum Vaccin Immunother. 2026 Dec;22(1):2611647. doi: 10.1080/21645515.2025.2611647. Epub 2026 Feb 2.

    PubMed 41628064

Questions about this trial

What is this clinical trial studying?

A study testing Motivational Interviewing and Information flyer in people with Vaccination Promotion, run by Observatoire Regional de la Sante Provence-Alpes-Côte d'Azur at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vaccine hesitancy score (Opel score) (time frame: During the 72-hour postpartum stay at the maternity ward). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05093452, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in